Acar'Up Consumer Health
PrivateLast Round
Early Funding
May 31, 2017
Est. Valuation
$4.01M
Total Funding Raised
$220,000
Company Overview
Acar'Up Consumer Health is a healthcare company that develops and markets ExAller, a clinically tested, plant-based solution designed to eliminate dust mites from homes to relieve allergy symptoms.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Home & Lifestyle, Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acar'Up Consumer Health Comps
Public and private peers based on sector, stage, and business model.
Acar'Up Consumer Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 31, 2017 | ||||
| Crowdfunding | Jun 1, 2015 | ||||
| Crowdfunding | Apr 1, 2013 |
Key People
Founding team and executive leadership
Acar'Up Consumer Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Innovation Fund | Early Funding |
| InVentures | Early Funding |
| Theodorus | Early Funding |
| Spreds | Crowdfunding, Early Funding |
Acar'Up Consumer Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Acar'Up Consumer Health's valuation, stock price, and market status.